We are an international
independent scientific network

devoted to advancing research on optimising the prevention,
diagnosis and treatment of infectious diseases in children globally

Linking experts from
around the world

in an independent global collaboration that seeks to standardize
best practices across disease areas and populations

Sharing values and goals

such as flexibility, commitment and transparency

Researching the right drug
and the right dose

to generate the scientific data necessary to market drugs
at doses that are safe and effective for children

Understanding the
immune response

so as to harness the body's response
to HIV and antiretrovirals

antimicrobial resistance

to ensure effective treatments are available
for common infections for generations to come

Paving the way for women,
children and their families

to make powerful informed decisions about their health
and healthcare and improve the quality of their lives

It’s time to recognise the movers and shakers in the maternal and child health field with Penta’s Brighter Future Award (BFA)!

From 15 June 2023, nominate anyone who deserves to be celebrated for going the extra mile to improve the health outcomes of children and pregnant people.

Get to know us

Penta is an international independent scientific network dedicated to child health. Our work is the result of a passionate collaboration between healthcare professionals and researchers in more than 110 centres across 31 countries around the world.

Through our studies and partnerships, we develop and deliver world-class research and training in paediatric infectious diseases to improve the lives of women and children, wherever they live.

Are you interested joining the Penta ID Network? Complete this form to apply.

Current Penta studies around the World

Always expanding

Penta continues to grow, bringing together healthcare professionals, researchers and scientists worldwide to address a wide range of healthcare issues.





Years of activity


Ongoing studies and projects

Latest News

D3 trial completes recruitment ahead of schedule!

14 Sep, 2023

The D3 trial is excited to announce that it has successfully completed recruitment in the trial at an exceptional speed. D3 is looking to see if a new tablet, a…
Read More

PediCAP trial completes recruitment, investigating more child-friendly treatment options for severe community-acquired pneumonia

01 Sep, 2023

The PediCAP team is pleased to report that the 1100 patients required for the main trial in this study have now been recruited. PediCAP is an innovative, EDCTP funded clinical…
Read More

Nominate now for the Penta Brighter Future Award: celebrating visionary healthcare heroes

28 Jul, 2023

Do you know someone making a significant difference in healthcare, particularly for women and children? The Penta Brighter Future Award is here to recognise and celebrate those unsung heroes who…
Read More

Penta leads new scientific collaboration to improve treatment and reduce mortality of neonatal sepsis in Africa

27 Jul, 2023

A new European-African collaboration to improve the way infections in newborns are treated is launching today. The project, called SNIP-AFRICA, aims to reduce mortality among neonates in hospital with sepsis…
Read More

Discovering Australia: a trip to the International Workshop on HIV Pediatrics 2023

27 Jul, 2023

A warm welcome to my blog, thank you for joining me for the conference adventures!!!  Flying to Brisbane, was a beautiful journey, it was my first time going out of…
Read More

Keep up to date with the latest Penta news

Sign up to receive our monthly Penta Newsletter filled with the latest news on our studies, projects and people